ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.685
      -0.12%
      Bitcoin
      65,240.95
      0.16%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Galapagos (GLPG)

      7. Galapagos (GLPG) News

      GLPG

      Galapagos (GLPG)

      Galapagos
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:GLPG
      DateTimeSourceHeadlineSymbolCompany
      03/03/20214:15PMGlobeNewswire Inc.Transparency notification received from The Capital GroupEU:GLPGGalapagos
      02/18/20214:01PMGlobeNewswire Inc.Pipeline and capital for growthEU:GLPGGalapagos
      02/18/20214:01PMGlobeNewswire Inc.Pipeline and capital for growthEU:GLPGGalapagos
      02/10/20219:40AMDow Jones NewsGilead, Galapagos Halt Trial of Pulmonary-Fibrosis TreatmentEU:GLPGGalapagos
      02/10/20219:00AMGlobeNewswire Inc.Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPFEU:GLPGGalapagos
      02/10/20219:00AMGlobeNewswire Inc.Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPFEU:GLPGGalapagos
      02/09/20214:01PMGlobeNewswire Inc.The Capital Group holds 10.03% of Galapagos sharesEU:GLPGGalapagos
      02/09/20214:01PMGlobeNewswire Inc.The Capital Group holds 10.03% of Galapagos sharesEU:GLPGGalapagos
      01/21/20212:08AMGlobeNewswire Inc.NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritisEU:GLPGGalapagos
      01/21/20212:08AMGlobeNewswire Inc.NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritisEU:GLPGGalapagos
      01/11/20214:01PMGlobeNewswire Inc.Gilead holds 25.54% of Galapagos sharesEU:GLPGGalapagos
      01/11/20214:01PMGlobeNewswire Inc.Gilead holds 25.54% of Galapagos sharesEU:GLPGGalapagos
      01/06/20219:30AMGlobeNewswire Inc.Galapagos to present at 39th Annual J.P. Morgan Healthcare ConferenceEU:GLPGGalapagos
      01/06/20219:30AMGlobeNewswire Inc.Galapagos to present at 39th Annual J.P. Morgan Healthcare ConferenceEU:GLPGGalapagos
      01/04/20214:01PMGlobeNewswire Inc.Selvita completes acquisition of Fidelta from GalapagosEU:GLPGGalapagos
      01/04/20214:01PMGlobeNewswire Inc.Selvita completes acquisition of Fidelta from GalapagosEU:GLPGGalapagos
      12/23/202012:00PMGlobeNewswire Inc.Galapagos’ CEO makes donation of €10 million in the form of personal shares to African ParksEU:GLPGGalapagos
      12/23/202012:00PMGlobeNewswire Inc.Galapagos’ CEO makes donation of €10 million in the form of personal shares to African ParksEU:GLPGGalapagos
      12/16/20201:21PMDow Jones NewsGalapagos Shares Drop 19% After Gilead Won't Seek FDA Approval for JyselecaEU:GLPGGalapagos
      12/16/20208:04AMDow Jones NewsGilead, Galapagos Amend Arrangement on Jyseleca; Gilead Won't Pursue FDA ApprovalEU:GLPGGalapagos
      12/15/20204:15PMGlobeNewswire Inc.Gilead  and  Galapagos  announce  New  Commercialization  and  Development  Agreement  for  Jyseleca®  (filgotini...EU:GLPGGalapagos
      12/15/20204:15PMGlobeNewswire Inc.Gilead  and  Galapagos  announce  New  Commercialization  and  Development  Agreement  for  Jyseleca®  (filgotini...EU:GLPGGalapagos
      12/04/20204:01PMGlobeNewswire Inc.Galapagos increases share capital through subscription right exercisesEU:GLPGGalapagos
      12/04/20204:01PMGlobeNewswire Inc.Galapagos increases share capital through subscription right exercisesEU:GLPGGalapagos
      12/01/20204:01PMGlobeNewswire Inc.Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney diseaseEU:GLPGGalapagos
      12/01/20204:01PMGlobeNewswire Inc.Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney diseaseEU:GLPGGalapagos
      11/30/20204:01PMGlobeNewswire Inc.Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial EU:GLPGGalapagos
      11/30/20204:01PMGlobeNewswire Inc.Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial EU:GLPGGalapagos
      11/23/20204:15PMGlobeNewswire Inc.Selvita to acquire Fidelta from GalapagosEU:GLPGGalapagos
      11/23/20204:15PMGlobeNewswire Inc.Selvita to acquire Fidelta from GalapagosEU:GLPGGalapagos
       Showing the most relevant articles for your search:EU:GLPG